The interaction of botrocetin with normal or variant von Willebrand factor (type IIA and IIB) and its inhibition by monoclonal antibodies that block receptor binding - Fujimura, Y; Miyata, S; Nishida, S; Miura, M; Kaneda, A; Yoshioka, A; Fukui, H; Katayama, M; Tudenham, E G D; Usami, Y; Titani, K (Thromb Haemost, 1992)